131 related articles for article (PubMed ID: 23354585)
1. Effectiveness and safety of aliskiren and aliskiren hydrochlorothiazide (HCT) in a multiethnic, real-world setting.
Maddury SR; Pande A; Haque KM; Echtay A; Go L; Gulzar T; Kadwa M; Hristoskova S
Adv Ther; 2013 Feb; 30(2):176-89. PubMed ID: 23354585
[TBL] [Abstract][Full Text] [Related]
2. Antihypertensive efficacy and tolerability of aliskiren/hydrochlorothiazide (HCT) single-pill combinations in patients who are non-responsive to HCT 25 mg alone.
Blumenstein M; Romaszko J; Calderón A; Andersen K; Ibram G; Liu Z; Zhang J
Curr Med Res Opin; 2009 Apr; 25(4):903-10. PubMed ID: 19245300
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of aliskiren/hydrochlorothiazide single-pill combinations in aliskiren non-responders.
Nickenig G; Simanenkov V; Lembo G; Rodriguez P; Salko T; Ritter S; Zhang J
Blood Press Suppl; 2008 Dec; 2():31-40. PubMed ID: 19203020
[TBL] [Abstract][Full Text] [Related]
4. Aliskiren as add-on therapy in the treatment of hypertensive diabetic patients inadequately controlled with valsartan/HCT combination: a placebo-controlled study.
Drummond W; Sirenko YM; Ramos E; Baek I; Keefe DL
Am J Cardiovasc Drugs; 2011 Oct; 11(5):327-33. PubMed ID: 21846154
[TBL] [Abstract][Full Text] [Related]
5. Long-term safety and tolerability of the oral direct renin inhibitor aliskiren with optional add-on hydrochlorothiazide in patients with hypertension: a randomized, open-label, parallel-group, multicentre, dose-escalation study with an extension phase.
Sica D; Gradman AH; Lederballe O; Kolloch RE; Zhang J; Keefe DL
Clin Drug Investig; 2011 Dec; 31(12):825-37. PubMed ID: 22035463
[TBL] [Abstract][Full Text] [Related]
6. Clinic and ambulatory blood pressure lowering effect of aliskiren/amlodipine/hydrochlorothiazide combination in patients with moderate-to-severe hypertension: a randomized active-controlled trial.
Lacourcière Y; Taddei S; Konis G; Fang H; Severin T; Zhang J
J Hypertens; 2012 Oct; 30(10):2047-55. PubMed ID: 22828090
[TBL] [Abstract][Full Text] [Related]
7. Aliskiren alone or in combination with hydrochlorothiazide in patients with the lower ranges of stage 2 hypertension: The ACQUIRE randomized double-blind study.
Black HR; Kribben A; Aguirre Palacios F; Bijarnia M; Laflamme AK; Baschiera F
J Clin Hypertens (Greenwich); 2010 Dec; 12(12):917-26. PubMed ID: 21122057
[TBL] [Abstract][Full Text] [Related]
8. Real-world effectiveness of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in high-risk patients and other subgroups.
Assaad-Khalil SH; Najem R; Sison J; Kitchlew AR; Cho B; Ueng KC; DiTommaso S; Shete A
Vasc Health Risk Manag; 2015; 11():71-8. PubMed ID: 25653536
[TBL] [Abstract][Full Text] [Related]
9. Long-term safety, tolerability and efficacy of combination therapy with aliskiren and amlodipine in patients with hypertension.
Littlejohn TW; Trenkwalder P; Hollanders G; Zhao Y; Liao W
Curr Med Res Opin; 2009 Apr; 25(4):951-9. PubMed ID: 19257800
[TBL] [Abstract][Full Text] [Related]
10. Long-term safety and efficacy of aliskiren and valsartan combination with or without the addition of HCT in patients with hypertension.
Chrysant SG; Murray AV; Hoppe UC; Dattani D; Patel S; Ritter S; Zhang J
Curr Med Res Opin; 2010 Dec; 26(12):2841-9. PubMed ID: 21062137
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of aliskiren 300 mg/hydrochlorothiazide 25 mg (± amlodipine 5 mg) in hypertensive patients not controlled by candesartan 32 mg plus HCT 25 mg.
Schweizer J; Ulmer HJ; Benduhn H; Klebs S
Curr Med Res Opin; 2011 Jan; 27(1):131-40. PubMed ID: 21117946
[TBL] [Abstract][Full Text] [Related]
12. Real-world clinical experience of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in hypertension: the EXCITE study.
Sison J; Assaad-Khalil SH; Najem R; Kitchlew AR; Cho B; Ueng KC; Shete A; Knap D
Curr Med Res Opin; 2014 Oct; 30(10):1937-45. PubMed ID: 25007309
[TBL] [Abstract][Full Text] [Related]
13. Aliskiren, an orally effective renin inhibitor, provides antihypertensive efficacy alone and in combination with valsartan.
Pool JL; Schmieder RE; Azizi M; Aldigier JC; Januszewicz A; Zidek W; Chiang Y; Satlin A
Am J Hypertens; 2007 Jan; 20(1):11-20. PubMed ID: 17198906
[TBL] [Abstract][Full Text] [Related]
14. Aliskiren alone or in combination with hydrochlorothiazide in Hispanic/Latino patients with systolic blood pressure 160 mm Hg to <180 mm Hg (Aliskiren Alone or in Combination with Hydrochlorothiazide in Patients with Stage 2 Hypertension to Provide Quick Intensive Control of Blood Pressure [ACQUIRE] substudy).
Black HR; Aguirre P F; Wright M; Alessi T; Baschiera F
J Clin Hypertens (Greenwich); 2012 Aug; 14(8):514-21. PubMed ID: 22863159
[TBL] [Abstract][Full Text] [Related]
15. Aliskiren-based therapy lowers blood pressure more effectively than hydrochlorothiazide-based therapy in obese patients with hypertension: sub-analysis of a 52-week, randomized, double-blind trial.
Schmieder RE; Philipp T; Guerediaga J; Gorostidi M; Bush C; Keefe DL
J Hypertens; 2009 Jul; 27(7):1493-501. PubMed ID: 19444142
[TBL] [Abstract][Full Text] [Related]
16. Phase IV, 8-week, multicenter, randomized, active treatment-controlled, parallel group, efficacy, and tolerability study of high-dose candesartan cilexetil combined with hydrochlorothiazide in Korean adults with stage II hypertension.
Lee HY; Hong BK; Chung WJ; Lee BK; Lee SH; Jeon DW; Ahn YK; Kim D; Park CK; Kim SH; Jung HO; Kim BO; Choi D
Clin Ther; 2011 Aug; 33(8):1043-56. PubMed ID: 21831438
[TBL] [Abstract][Full Text] [Related]
17. Use of aliskiren in Latin America in a real-world setting: aliskiren in Latin America Study (ALAS).
Volman S; Benitez FN; Cedenio H; Giorgi M; Jaramillo N; Molina N; Zilberman J
Ther Adv Cardiovasc Dis; 2013 Aug; 7(4):189-96. PubMed ID: 23723254
[TBL] [Abstract][Full Text] [Related]
18. An observational, prospective, open-label, multicentre evaluation of aliskiren in treated, uncontrolled patients: a real-life, long-term, follow-up, clinical practice in Italy.
Tocci G; Aimo G; Caputo D; De Matteis C; Di Napoli T; Granatelli A; Lentini P; Magagna A; Matarrese AA; Perona D; Villa G; Volpe M;
High Blood Press Cardiovasc Prev; 2012 Jun; 19(2):73-83. PubMed ID: 22867093
[TBL] [Abstract][Full Text] [Related]
19. Antihypertensive efficacy and tolerability of aliskiren/amlodipine single- pill combinations in patients with an inadequate response to aliskiren monotherapy.
Glorioso N; Thomas M; Troffa C; Argiolas G; Patel S; Baek I; Zhang J
Curr Vasc Pharmacol; 2012 Nov; 10(6):748-55. PubMed ID: 22303910
[TBL] [Abstract][Full Text] [Related]
20. Long-term safety, tolerability and efficacy of aliskiren in combination with valsartan in patients with hypertension: a 6-month interim analysis.
Chrysant SG; Murray AV; Hoppe UC; Dattani D; Patel S; Hsu H; Zhang J
Curr Med Res Opin; 2008 Apr; 24(4):1039-47. PubMed ID: 18307835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
